Arkadios Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.8M | Buy |
42,008
+3,963
| +10% | +$736K | 0.23% | 94 |
|
|
2025
Q1 | $7.97M | Buy |
38,045
+4,179
| +12% | +$876K | 0.3% | 65 |
|
|
2024
Q4 | $6.02M | Sell |
33,866
-109
| -0.3% | -$19.4K | 0.33% | 59 |
|
|
2024
Q3 | $6.71M | Buy |
33,975
+3,334
| +11% | +$658K | 0.38% | 54 |
|
|
2024
Q2 | $5.26M | Buy |
30,641
+3,120
| +11% | +$535K | 0.35% | 52 |
|
|
2024
Q1 | $5.01M | Sell |
27,521
-504
| -2% | -$91.8K | 0.39% | 50 |
|
|
2023
Q4 | $4.34M | Sell |
28,025
-6,295
| -18% | -$976K | 0.37% | 56 |
|
|
2023
Q3 | $5.12M | Buy |
34,320
+9,715
| +39% | +$1.45M | 0.49% | 44 |
|
|
2023
Q2 | $3.31M | Sell |
24,605
-1,720
| -7% | -$232K | 0.39% | 61 |
|
|
2023
Q1 | $4.2M | Buy |
26,325
+1,738
| +7% | +$277K | 0.5% | 44 |
|
|
2022
Q4 | $3.97M | Buy |
24,587
+3,679
| +18% | +$595K | 0.53% | 46 |
|
|
2022
Q3 | $2.81M | Sell |
20,908
-9,535
| -31% | -$1.28M | 0.43% | 60 |
|
|
2022
Q2 | $4.66M | Buy |
30,443
+2,738
| +10% | +$419K | 0.69% | 28 |
|
|
2022
Q1 | $4.49M | Buy |
27,705
+5,142
| +23% | +$834K | 0.59% | 37 |
|
|
2021
Q4 | $3.06M | Buy |
22,563
+2,450
| +12% | +$332K | 0.4% | 59 |
|
|
2021
Q3 | $2.17M | Buy |
20,113
+1,455
| +8% | +$157K | 0.31% | 85 |
|
|
2021
Q2 | $2.1M | Buy |
18,658
+12,343
| +195% | +$1.39M | 0.26% | 105 |
|
|
2021
Q1 | $683K | Buy |
6,315
+764
| +14% | +$82.6K | 0.11% | 206 |
|
|
2020
Q4 | $594K | Buy |
5,551
+3,325
| +149% | +$356K | 0.12% | 172 |
|
|
2020
Q3 | $192K | Buy |
2,226
+489
| +28% | +$42.2K | 0.1% | 184 |
|
|
2020
Q2 | $172K | Buy |
1,737
+161
| +10% | +$15.9K | 0.1% | 170 |
|
|
2020
Q1 | $120K | Buy |
1,576
+23
| +1% | +$1.75K | 0.08% | 212 |
|
|
2019
Q4 | $148K | Buy |
+1,553
| New | +$148K | 0.09% | 184 |
|